A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Kortrijk, Belgium
- Facility name not stated
Leuven, Belgium
- Facility name not stated
Wilrijk, Belgium
- Facility name not stated
Clermont-Ferrand, France
- Facility name not stated
Marseille, France
- Facility name not stated
Pessac, France
- Facility name not stated
Rouen, France
- Facility name not stated
Tours, France
- Facility name not stated
Bologna, Italy
- Facility name not stated
Varese, Italy
- Facility name not stated
Badalona, Barcelona, Spain
- Facility name not stated
Barcelona, Spain
- Facility name not stated
Madrid, Spain
- Facility name not stated
Salamanca, Spain
- Facility name not stated
Leeds, United Kingdom
- Facility name not stated
London, United Kingdom
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Palo Alto, California, United States
- Facility name not stated
Hackensack, New Jersey, United States
- Facility name not stated
Rochester, New York, United States
- Facility name not stated
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2014
- Primary completion
- 17 Jan 2017
- Completion
- 31 May 2017
- Last update posted
- 28 Sept 2023
- Registered enrollment
- 55
- Registry id
- NCT02391545
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.